Elite in Ataxia-Telangiectasia

William P. Whitehouse

Nottingham, ENG, GB 
Clinical Trials:Currently Recruiting for 2 Trials
Elite in Ataxia-Telangiectasia
Nottingham, ENG, GB 
OverviewLocationsClinical Research

Overview

William Whitehouse practices in Nottingham, United Kingdom. Mr. Whitehouse is rated as an Elite expert by MediFind in the treatment of Ataxia-Telangiectasia. His top areas of expertise are Ataxia-Telangiectasia, Telangiectasia, Aicardi-Goutieres Syndrome, and Myoclonic Epilepsy.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 16 articles and participated in 1 clinical trial in the study of Ataxia-Telangiectasia.

Gender
Male

Locations

Nottingham, ENG, United Kingdom
Other Locations
Derby, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Recruiting
Publish Date: October 09, 2025
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
A Phase III Multi-centre Randomised, Double Blind, Placebo Controlled Trial to Assess the Role of Intravenous Immunoglobulin in the Management of Children With Encephalitis
Enrollment Status: Completed
Publish Date: March 04, 2024
Intervention Type: Drug
Study Drug: Immunoglobulins
Study Phase: Phase 3
Feasibility of Whole-body MRI for Cancer Surveillance in Children and Young People With Ataxia Telangiectasia
Feasibility of Whole-body MRI for Cancer Surveillance in Children and Young People With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Diagnostic test
View 2 Less Clinical Trial

71 Total Publications

Bilateral Greater Occipital Nerve injections could be useful in migraine status presenting to paediatric emergency departments.
Bilateral Greater Occipital Nerve injections could be useful in migraine status presenting to paediatric emergency departments.
Journal: European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
Published: April 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Whitehouse's expertise for a condition
ConditionClose
View All 22 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile